Nigel Taylor
- Partner
- Corporate
Wedlake Bell has advised the shareholders of Estima Scientific Ltd on the sale of the entire issued share capital to EVERSANA.
Estima Scientific is a London-based health economics and outcomes research (HEOR) technology and services company. By combining specialist consulting with proprietary, AI-powered software, Estima Scientific helps pharmaceutical and biotechnology companies demonstrate therapeutic value to global payers and health technology assessment bodies efficiently. The company has built a strong base of global clients that rely on its proprietary AI-powered technology to support research studies for leading global pharmaceutical brands.
EVERSANA is an independent provider of modern commercialisation services to the biopharmaceutical industry. Its integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers, and it serves more than 650 organisations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. EVERSANA is a global provider of modern, AI-powered commercial services for the biopharmaceutical industry
Tim Reason, co-founder of Estima Scientific, said “We are delighted to have completed the sale of Estima Scientific to Eversana. The Wedlake Bell team provided clear, pragmatic advice throughout the process and were instrumental in helping us navigate the transaction and bring it to a successful conclusion. We are very grateful to Nigel, James, Tom and Enea, as well as the wider team for their commitment and support.”
Nigel Taylor, Corporate Partner at Wedlake Bell, commented: “We are delighted to have advised on the sale of Estima Scientific to Eversana. It has been a real pleasure working with Tim, Andy and the wider team throughout the process. This was an important transaction for all involved, and we are very pleased to have helped bring it to a successful conclusion. We wish the business every success for the next stage of its development.”
Wedlake Bell’s M&A team was led by Nigel Taylor (Partner, Corporate), with support from James French (Senior Associate, Corporate), Tom Boersma (Senior Associate, Corporate) and Enea Aniaj (Solicitor, Corporate). Specialist support was provided by Mike Ridsdale (Partner) and Lucy Foster (Solicitor) on corporate tax matters, Choy Lau (Legal Director) on employment matters, and Adam Betts (Partner) and Emma Thomas (Solicitor) on IP and commercial matters.
Meet the team:
James French
- Senior Associate
- Corporate
Tom Boersma
- Senior Associate
- Corporate